Pages that link to "Q34350695"
Jump to navigation
Jump to search
The following pages link to Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding (Q34350695):
Displaying 50 items.
- Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 (Q24316428) (← links)
- A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32 (Q24540252) (← links)
- Dyslipidaemia in the Middle East: Current status and a call for action (Q26741558) (← links)
- Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia (Q26787050) (← links)
- Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents (Q26798119) (← links)
- Murine models of hepatitis C: what can we look forward to? (Q26991875) (← links)
- Profile of evolocumab and its potential in the treatment of hyperlipidemia (Q27004235) (← links)
- Next-generation gene discovery for variants of large impact on lipid traits (Q28088415) (← links)
- Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia (Q28259861) (← links)
- Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia (Q28716905) (← links)
- PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease (Q30234612) (← links)
- The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. (Q31685318) (← links)
- Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary (Q31798357) (← links)
- Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia (Q33595177) (← links)
- Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia (Q33599900) (← links)
- A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia (Q33614636) (← links)
- Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC) (Q33630769) (← links)
- Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia (Q33642312) (← links)
- Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. (Q33688317) (← links)
- Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver (Q33728993) (← links)
- Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples? (Q33829131) (← links)
- Genetic basis of lipoprotein disorders (Q33847743) (← links)
- Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells (Q33898251) (← links)
- Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor (Q33910296) (← links)
- Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). (Q33910842) (← links)
- Genome-wide linkage scan of a pedigree with familial hypercholesterolemia suggests susceptibility loci on chromosomes 3q25-26 and 21q22. (Q34055467) (← links)
- Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents (Q34201954) (← links)
- Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice (Q34250947) (← links)
- Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs (Q34430377) (← links)
- Evidence of how rs7575840 influences apolipoprotein B-containing lipid particles (Q34843343) (← links)
- Familial hypercholesterolemia: the lipids or the genes? (Q35014525) (← links)
- Molecular spectrum of autosomal dominant hypercholesterolemia in France (Q35153026) (← links)
- Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100 (Q35198304) (← links)
- Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis (Q35248302) (← links)
- Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia. (Q35435218) (← links)
- Premature coronary artery disease and familial hypercholesterolemia: need for early diagnosis and cascade screening in the Indian population (Q35494775) (← links)
- Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse (Q35553097) (← links)
- Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity (Q35553545) (← links)
- Lowering cholesterol, 1988. Rationale, mechanisms, and means (Q35588973) (← links)
- Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders (Q35696516) (← links)
- The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma (Q35824543) (← links)
- Apolipoprotein genes and atherosclerosis (Q35878149) (← links)
- Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia (Q35897064) (← links)
- LDL-receptor mutations in Europe (Q35938094) (← links)
- Absence of Apo B R3500Q Mutation among Kelantanese Malays with Hyperlipidaemia (Q36120476) (← links)
- Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia (Q36186468) (← links)
- Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity (Q36353492) (← links)
- Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population (Q36634114) (← links)
- ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature (Q36679415) (← links)
- Common and rare gene variants affecting plasma LDL cholesterol (Q36711327) (← links)